Skip to main content

Table 2 Association of quartiles of pan-immune inflammation value on study outcomes

From: Association of pan-immune inflammation value and lung health in adults

 

Model I

P value

Model II

P value

Model III

P value

Symptoms, OR (95%CI)

 Cough

      

  PIV100 per SD

1.20 (1.07, 1.34)

0.002

1.12 (1.03, 1.25)

0.042

1.08 (1.01, 1.10)

0.023

  Q1

Ref

 

Ref

 

Ref

 

  Q2

1.74 (1.34, 2.28)

 < 0.001

1.64 (1.25, 2.15)

 < 0.001

1.57 (1.18, 2.11)

0.002

  Q3

2.04 (1.57, 2.65)

 < 0.001

1.87 (1.44, 2.44)

 < 0.001

1.65 (1.24, 2.21)

 < 0.001

  Q4

2.56 (1.99, 3.31)

 < 0.001

2.24 (1.73, 2.92)

 < 0.001

1.94 (1.47, 2.57)

 < 0.001

  P for trend

 

 < 0.001

 

 < 0.001

 

 < 0.001

 Phlegm

      

  PIV100 per SD

1.16 (1.05, 1.31)

0.014

1.11 (1.02, 1.25)

0.064

1.07 (1.00, 1.17)

0.037

  Q1

Ref

 

Ref

 

Ref

 

  Q2

1.58 (1.19, 2.11)

0.002

1.54 (1.15, 2.05)

0.003

1.43 (1.05, 1.96)

0.023

  Q3

1.84 (1.40, 2.44)

 < 0.001

1.77 (1.34, 2.36)

 < 0.001

1.55 (1.14, 2.11)

0.005

  Q4

2.35 (1.80, 3.08)

 < 0.001

2.19 (1.67, 2.90)

 < 0.001

1.85 (1.38, 2.50)

 < 0.001

  P for trend

 

 < 0.001

 

 < 0.001

 

 < 0.001

 Wheeze

      

  PIV100 per SD

1.07 (1.00, 1.17)

0.092

1.08 (1.01, 1.19)

0.054

1.05 (0.99,1.13)

0.092

  Q1

Ref

 

Ref

 

Ref

 

  Q2

1.15 (0.93, 1.42)

0.211

1.22 (0.99, 1.52)

0.069

1.22 (0.96, 1.55)

0.1

  Q3

1.31 (1.06, 1.62)

0.011

1.44 (1.16, 1.78)

 < 0.001

1.31 (1.03, 1.65)

0.026

  Q4

1.56 (1.27, 1.91)

 < 0.001

1.70 (1.37, 2.10)

 < 0.001

1.47 (1.17, 1.86)

0.001

  P for trend

 

 < 0.001

 

 < 0.001

 

0.001

 Exertional dyspnea

      

  PIV100 per SD

1.04 (0.95, 1.11)

0.264

1.04 (0.95, 1.11)

0.257

1.03 (0.89, 1.10)

0.579

  Q1

Ref

 

Ref

 

Ref

 

  Q2

1.35 (0.98, 1.87)

0.072

1.35 (0.97, 1.88)

0.076

1.18 (0.83, 1.68)

0.369

  Q3

1.19 (0.85,1.66)

0.308

1.18 (0.84, 1.66)

0.34

0.99 (0.69, 1.43)

0.955

  Q4

1.38 (1.00, 1.91)

0.051

1.37 (0.98, 1.91)

0.066

1.14 (0.80, 1.63)

0.472

  P for trend

 

0.115

 

0.15

 

0.715

Diseases, OR (95%CI)

 Asthma

      

  PIV100 per SD

1.01 (0.92, 1.07)

0.798

1.02 (0.93, 1.09)

0.502

1.01 (0.89, 1.08)

0.865

  Q1

Ref

 

Ref

 

Ref

 

  Q2

0.97 (0.78, 1.21)

0.781

1.02 (0.82, 1.27)

0.876

0.98 (0.77, 1.25)

0.895

  Q3

1.12 (0.91, 1.38)

0.3

1.18 (0.95, 1.47)

0.138

1.16 (0.92, 1.47)

0.212

  Q4

1.11 (0.90, 1.38)

0.329

1.16 (0.93, 1.45)

0.181

1.07 (0.84, 1.36)

0.587

  P for trend

 

0.179

 

0.093

 

0.354

 Emphysema

      

  PIV100 per SD

1.06 (0.96, 1.13)

0.095

1.07 (0.93, 1.15)

0.101

1.04 (0.78, 1.18)

0.756

  Q1

Ref

 

Ref

 

Ref

 

  Q2

1.61 (0.85, 3.15)

0.151

1.39 (0.73, 2.74)

0.325

1.02 (0.50, 2.10)

0.959

  Q3

2.92 (1.65, 5.45)

 < 0.001

2.39 (1.34, 4.52)

0.005

1.58 (0.84, 3.08)

0.166

  Q4

3.20 (1.83, 5.94)

 < 0.001

2.27 (1.28, 4.28)

0.007

1.35 (0.72, 2.64)

0.358

  P for trend

 

 < 0.001

 

0.002

 

0.225

 Chronic bronchitis

      

  PIV100 per SD

1.05 (0.98, 1.13)

0.115

1.06 (0.98, 1.13)

0.053

1.05 (0.93, 1.12)

0.239

  Q1

Ref

 

Ref

 

Ref

 

  Q2

1.25 (0.92, 1.70)

0.161

1.24 (0.91, 1.70)

0.171

1.15 (0.81, 1.63)

0.443

  Q3

1.33 (0.98, 1.81)

0.066

1.29 (0.95, 1.77)

0.109

1.26 (0.90, 1.77)

0.189

  Q4

1.55 (1.16, 2.09)

0.003

1.47 (1.09, 2.01)

0.013

1.24 (0.88, 1.75)

0.215

  P for trend

 

0.003

 

0.016

 

0.198

Lung function measures, c (95%CI)

 FEV1

      

 PIV100 per SD

−0.70 (−20.8, 19.4)

0.946

−31.04 (−44.66, −17.43)

 < 0.001

−19.42 (−32.92, −5.92)

0.005

 Q1

Ref

 

Ref

 

Ref

 

 Q2

69.55 (12.69, 126.40)

0.017

−42.69 (−81.09, −4.29)

0.029

−32.02 (−71.41, 7.37)

0.111

 Q3

29.90 (−26.99, 86.76)

0.303

−93.86 (−132.68, −55.03)

 < 0.001

−65.06 (−104.90, −25.22)

0.001

 Q4

−41.82 (−98.68, 15.03)

0.149

−191.91 (−231.05, −152.77)

 < 0.001

−146.29 (−186.41, −106.17)

 < 0.001

 P for trend

 

0.072

 

 < 0.001

 

 < 0.001

 FEV1%

      

  PIV100 per SD

−0.83 (−1.25, −0.40)

 < 0.001

−0.72 (−1.14, −0.29)

 < 0.001

−0.36 (−0.78, 0.07)

0.1

  Q1

Ref

 

Ref

 

Ref

 

  Q2

−1.18 (−2.38, 0.02)

0.053

−1.12 (−2.32, 0.09)

0.069

−0.86 (−2.10, 0.38)

0.176

  Q3

−2.28 (−3.48, −1.09)

 < 0.001

−2.23 (−3.45, −1.01)

 < 0.001

−1.41 (−2.66, −0.15)

0.028

  Q4

−4.77 (−5.96, −3.57)

 < 0.001

−4.41 (−5.63, −3.18)

 < 0.001

−2.99 (−4.25, −1.72)

 < 0.001

  P for trend

 

 < 0.001

 

 < 0.001

 

 < 0.001

 FVC

      

  PIV100 per SD

16.89 (−8.97, 42.76)

0.201

−33.52 (−50.14, −16.91)

 < 0.001

−20.78 (−37.39, −4.17)

0.014

  Q1

Ref

 

Ref

 

Ref

 

  Q2

110.15 (7.04, 183.25)

0.003

−55.44 (−102.39, −8.50)

0.021

−48.97 (−97.51, −0.43)

0.048

  Q3

103.71 (30.59, 176.82)

0.005

−80.55 (−128.02, −33.09)

 < 0.001

−54.26 (−103.35, −5.16)

0.03

  Q4

34.84 (−38.27, 107.94)

0.35

−206.21 (−254.07, −158.36)

 < 0.001

−157.02 (−206.45, −107.58)

 < 0.001

  P for trend

 

0.406

 

 < 0.001

 

 < 0.001

 FVC%

      

  PIV100 per SD

−0.57 (−0.94, −0.19)

0.003

−0.52 (−0.90, −0.15)

0.007

−0.22 (−0.60, 0.16)

0.258

  Q1

Ref

 

Ref

 

Ref

 

  Q2

−1.08 (−2.14, −0.02)

0.047

−1.07 (−2.14, 0.00)

0.049

−0.99 (−2.10, 0.12)

0.08

  Q3

−1.22 (−2.28, −0.16)

0.025

−1.20 (−2.28, −0.12)

0.03

−0.71 (−1.84, 0.41)

0.213

  Q4

−3.40 (−4.46, −2.34)

 < 0.001

−3.28 (−4.37, −2.19)

 < 0.001

−2.16 (−3.29, −1.02)

 < 0.001

  P for trend

 

 < 0.001

 

 < 0.001

 

 < 0.001

 FEV1/FVC

      

  PIV100 per SD

−0.44 (−0.64, −0.23)

 < 0.001

−0.21 (−0.41, −0.02)

0.03

−0.16 (−0.35, 0.04)

0.11

  Q1

Ref

 

Ref

 

Ref

 

  Q2

−0.52 (−1.11, 0.06)

0.081

−0.14 (−0.69, 0.41)

0.614

0.03 (−0.54, 0.60)

0.918

  Q3

−1.46 (−2.05, −0.88)

 < 0.001

−1.00 (−1.56, −0.45)

 < 0.001

−0.68 (−1.26, −0.10)

0.021

  Q4

−1.98 (−2.57, −1.40)

 < 0.001

−1.05 (−1.61, −0.50)

 < 0.001

−0.75 (−1.33, −0.16)

0.012

  P for trend

 

 < 0.001

 

 < 0.001

 

0.002

Spirometry pattern, RRR (95%CI)

 Obstructive

      

  PIV100 per SD

1.24 (1.13, 1.37)

 < 0.001

1.11 (1.02, 1.22)

0.038

1.06 (1.00, 1.15)

0.069

  Q1

Ref

 

Ref

 

Ref

 

  Q2

1.23 (1.02, 1.49)

0.03

1.17 (0.96, 1.43)

0.124

1.11 (0.89, 1.38)

0.348

  Q3

1.54 (1.28, 1.85)

 < 0.001

1.48 (1.21, 1.80)

 < 0.001

1.34 (1.08, 1.66)

0.009

  Q4

1.88 (1.57, 2.26)

 < 0.001

1.63 (1.34, 1.98)

 < 0.001

1.45 (1.17, 1.80)

 < 0.001

  P for trend

 

 < 0.001

 

 < 0.001

 

 < 0.001

 Restrictive

      

  PIV100 per SD

1.05 (0.99,1.16)

0.121

1.06 (0.99,1.17)

0.109

1.03 (0.96, 1.11)

0.265

  Q1

Ref

 

Ref

 

Ref

 

  Q2

1.14 (0.88, 1.48)

0.315

1.23 (0.94, 1.60)

0.129

1.20 (0.90, 1.60)

0.216

  Q3

1.06 (0.81, 1.39)

0.657

1.19 (0.90, 1.56)

0.222

1.11 (0.82, 1.49)

0.504

  Q4

1.64 (1.28, 2.11)

 < 0.001

1.82 (1.41, 2.37)

 < 0.001

1.52 (1.15, 2.03)

0.004

  P for trend

 

 < 0.001

 

 < 0.001

 

0.009

  1. Abbreviations: PIV100 pan-immune inflammation value divided by 100, SD standard deviation, Q quartile, OR odds ratio, MD mean difference, RRR relative risk ratio, CI confidence interval, FEV1 forced expiratory volume 1st second, FEV1% percent-predicted forced expiratory volume 1st second, FVC forced vital capacity, FVC% percent-predicted forced vital capacity
  2. Model I was adjusted for none
  3. Model II was adjusted for age, gender and race
  4. Model III was adjusted for age, gender, race, education level, marital status, smoke, drink, PIR, hypertension, diabetes mellitus, CAD, liver problem, arthritis, thyroid problem and cancer